Sabra Health Care Stock Fundamentals
| SBC Stock | EUR 17.49 0.09 0.52% |
Sabra Health Care fundamentals help investors to digest information that contributes to Sabra Health's financial success or failures. It also enables traders to predict the movement of Sabra Stock. The fundamental analysis module provides a way to measure Sabra Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sabra Health stock.
Sabra |
Sabra Health Care Company Return On Equity Analysis
Sabra Health's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sabra Health Return On Equity | -0.0241 |
Most of Sabra Health's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sabra Health Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sabra Health Care has a Return On Equity of -0.0241. This is 98.23% lower than that of the Real Estate sector and 100.28% lower than that of the REIT - Healthcare Facilities industry. The return on equity for all Germany stocks is 92.23% lower than that of the firm.
Sabra Health Care Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sabra Health's current stock value. Our valuation model uses many indicators to compare Sabra Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sabra Health competition to find correlations between indicators driving Sabra Health's intrinsic value. More Info.Sabra Health Care is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sabra Health's earnings, one of the primary drivers of an investment's value.Sabra Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sabra Health's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sabra Health could also be used in its relative valuation, which is a method of valuing Sabra Health by comparing valuation metrics of similar companies.Sabra Health is currently under evaluation in return on equity category among its peers.
Sabra Fundamentals
| Return On Equity | -0.0241 | |||
| Return On Asset | 0.0155 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.27 % | |||
| Current Valuation | 5.1 B | |||
| Shares Outstanding | 231.16 M | |||
| Shares Owned By Insiders | 1.35 % | |||
| Shares Owned By Institutions | 90.40 % | |||
| Price To Earning | 25.24 X | |||
| Price To Book | 0.90 X | |||
| Price To Sales | 6.70 X | |||
| Revenue | 624.81 M | |||
| Gross Profit | 372.8 M | |||
| EBITDA | 216.89 M | |||
| Net Income | (77.61 M) | |||
| Cash And Equivalents | 56.81 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.31 B | |||
| Debt To Equity | 106.60 % | |||
| Current Ratio | 5.91 X | |||
| Book Value Per Share | 13.23 X | |||
| Cash Flow From Operations | 315.73 M | |||
| Earnings Per Share | (0.33) X | |||
| Target Price | 19.14 | |||
| Number Of Employees | 42 | |||
| Beta | 1.29 | |||
| Market Capitalization | 2.59 B | |||
| Total Asset | 5.75 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.09 % | |||
| Net Asset | 5.75 B | |||
| Last Dividend Paid | 1.2 |
About Sabra Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sabra Health Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sabra Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sabra Health Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.As of March 31, 2019, Sabras investment portfolio included 437 real estate properties held for investment 304 Skilled NursingTransitional Care facilities, 88 Senior Housing communities , 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements and 22 Specialty Hospitals and Other facilities, 30 assets held for sale, one investment in a direct financing lease, 20 investments in loans receivable one mortgage loan, two construction loans and 17 other loans, nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing Managed communities. As of March 31, 2019, Sabras real estate properties held for investment included 43,884 bedsunits and its unconsolidated joint venture included 7,652 bedsunits, spread across the United States and Canada
Currently Active Assets on Macroaxis
Other Information on Investing in Sabra Stock
Sabra Health financial ratios help investors to determine whether Sabra Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sabra with respect to the benefits of owning Sabra Health security.